Y-mAbs Signs License Agreement with SciClone for DANYELZA® (naxitamab-gqgk) and Omburtamab in China

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing